Yes this exactly!
The way that management have previously under estimated/under forecasted and then over delivered makes me more confident in the 4 x overall survival comment.
To add to this, the studies are taking longer than expected. I was first concerned about this but could it be because their patients are surviving much longer than originally anticipated?
Which in turn extends the study because results are so positive? With data not recorded until it’s final? Purely speculation but backed by logic and past performance
Further to this, CAIX could be effective in over 20 different cancer sites. This is unbelievably massive.
Eg. TLX591 is specific to prostate and could potentially pull in 10 billion USD + annually if successful. This is one site not 20 like CAIX in starburst
what happens if starburst is successful and is able treat at 20 different cancer sites?
I know oldsport Tony hairdresser gets upset about me comparing TLX to CSL but TLX could actually be bigger one day if all stars align and management stays rock solid
DYOR but critics are welcome to pull this apart with logic
Regards MR.COMPOUNDER50
Yes this exactly! The way that management have previously under...
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.24 |
Change
0.440(2.97%) |
Mkt cap ! $5.036B | |||
| Open | High | Low | Value | Volume |
| $14.71 | $15.24 | $14.61 | $17.69M | 1.179M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2333 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 10000 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$15.21 |
Change
0.440 ( 2.60 %) |
||||
| Open | High | Low | Volume | ||
| $14.73 | $15.24 | $14.62 | 327752 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| TLX (ASX) Chart |